KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Common Equity (2016 - 2025)

Historic Common Equity for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $2.5 billion.

  • Exact Sciences' Common Equity fell 2208.66% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 2208.66%. This contributed to the annual value of $2.4 billion for FY2024, which is 2362.43% down from last year.
  • Latest data reveals that Exact Sciences reported Common Equity of $2.5 billion as of Q3 2025, which was down 2208.66% from $2.5 billion recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Common Equity ranged from a high of $3.6 billion in Q1 2021 and a low of $2.4 billion during Q1 2025
  • Over the past 5 years, Exact Sciences' median Common Equity value was $3.1 billion (recorded in 2024), while the average stood at $3.1 billion.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 5153.46% in 2021, then crashed by 2362.43% in 2024.
  • Over the past 5 years, Exact Sciences' Common Equity (Quarter) stood at $3.4 billion in 2021, then fell by 10.17% to $3.0 billion in 2022, then rose by 3.36% to $3.1 billion in 2023, then fell by 23.62% to $2.4 billion in 2024, then rose by 4.13% to $2.5 billion in 2025.
  • Its Common Equity was $2.5 billion in Q3 2025, compared to $2.5 billion in Q2 2025 and $2.4 billion in Q1 2025.